Showing articles associated with Richard Tarrant
Richard Tarrant, PhD and BSc, became a Qualified Person (QP) for the Clinical BioManufacturing Facility (CBF) in October 2018.
Richard has worked at the CBF since April 2013, working initially as Quality Control Manager and from October 2016 until December 2018 as Quality Assurance Manager. Prior to this, Richard completed a PhD in Biochemical Engineering at UCL and had 3 years’ experience at Lonza Biologics, working within Purification Development as a Study Director of GMP Virus Validation studies and in other roles at GlaxoSmithKline and the Medicines and Healthcare products Regulatory Agency (MHRA). Richard was the QP responsible for certification of the first batch of ChAdOx1 nCoV-19 manufactured at the CBF in April 2020 and has since been responsible for the certification of larger-scale batches manufactured by a Contract Manufacturing Organisation (CMO) based in Italy.